Article Information
PubMed
Print ISSN
Online ISSN
History
- Published online January 18, 2023.
Article Versions
- You are currently viewing an Earlier version of this article (January 18, 2023 - 08:18).
- View the most recent version of this article
Copyright & Usage
© 2020 The Authors. This is an open access article under the terms of the Creative Commons Attribution Non-Commercial License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited and is not used for commercial purposes.
Author Information
- Ulrik Jurva1,*,
- Lars Weidolf2,
- Ann-Sofie Sandinge1,
- Carina Leandersson3,
- Anja Ekdahl1,
- Xue-Qing Li4,
- Thomas Antonsson5,
- Johan Sundell5,
- Kristina Westerlund5,
- Carl Amilon6,
- Tord Inghardt5, and
- V. Sashi Gopaul7
- 1Drug Metabolism and Pharmacokinetics (DMPK), Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Sweden
- 2iMed CVMD DMPK, AstraZeneca R&D Molndal, Sweden
- 3Drug Metabolism and Pharmacokinetics (DMPK), Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Sweden
- 4CVMD iMed DMPK, AstraZeneca R&D Mölndal, Sweden
- 5Medicinal Chemistry, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Sweden
- 6Formerly of Drug Metabolism and Pharmacokinetics (DMPK), Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM) BioPharmaceuticals R&D, AstraZeneca, Sweden
- 7Early Research and Development Cardiovascular Renal and Metabolism, AstraZeneca R&D Gothenburg, Sweden
- ↵* Corresponding Author:
Ulrik Jurva, Drug Metabolism and Pharmacokinetics (DMPK), Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, N/A, Sweden. E-mail: Ulrik.jurva{at}astrazeneca.com